First Advantage to Participate in Evercore ISI Payments & Fintech Innovators Forum
23 févr. 2023 08h43 HE
|
First Advantage Corporation
ATLANTA, Feb. 23, 2023 (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a leading global provider of employment background screening and verification solutions, today announced that...
Syneos Health to Participate in Fireside Chat at the 2022 Evercore ISI HealthCONx Conference
17 nov. 2022 16h44 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer...
Revolution Medicines to Participate in Upcoming Investor Conferences
09 nov. 2022 16h05 HE
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
Otonomo to Present at Evercore ISI Technology Conference in NYC
31 août 2022 08h00 HE
|
OTONOMO TECHNOLOGIES LTD
HERZLIYA, Israel and SAN FRANCISCO, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Otonomo Technologies Ltd. (Nasdaq: OTMO), the platform powering the mobility economy, today announced that Ben Volkow, CEO, will...
Revolution Medicines to Participate in 4th Annual Evercore ISI HealthCONx Conference
24 nov. 2021 07h30 HE
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Nov. 24, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing targeted drugs to inhibit...
Cerence to Present at the Evercore ISI Autotech & AI Forum
15 sept. 2021 16h30 HE
|
Cerence Inc.
BURLINGTON, Mass., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, announced today that it will be presenting at the Evercore ISI Autotech & AI Forum on...
Surface Oncology to Present at Evercore ISI 2nd Annual HealthCONx Conference
26 nov. 2019 08h00 HE
|
Surface Oncology, Inc.
CAMBRIDGE, Mass., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Incysus Therapeutics to Participate in Evercore ISI HealthCONx Conference
26 nov. 2019 07h00 HE
|
Incysus Therapeutics, Inc.
NEW YORK, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
ProQR to Present at Upcoming Investor Conferences
13 nov. 2019 07h00 HE
|
ProQR Therapeutics N.V.
LEIDEN, Netherlands and CAMBRIDGE, Mass., Nov. 13, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of...
Sorrento CEO to Present at Upcoming Investor Conferences
12 nov. 2019 07h05 HE
|
Sorrento Therapeutics, Inc.
SAN DIEGO, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, will participate in upcoming investor...